Leveraging patient data to detect systematic shifts in daptomycin susceptibility testing associated with reduced prescribing

Authors

• Mark A Zaydman, Washington University School of Medicine in St. Louis
• Laurel Glaser, University of Pennsylvania
• Daniel S Herman, University of Pennsylvania
• Mason Kressloff, University of Pennsylvania
• Vahid Azimi, Alameda Health System
• Christine R Lockowitz, St. Louis Children's Hospital
• Rebekah E Dumm, Washington University School of Medicine in St. Louis

Journal

Journal of Clinical Microbiology

Publication Date

3-11-2026

Volume

64

Issue

3

First Page

e0151025

Document Type

Open Access Publication

DOI

10.1128/jcm.01510-25

Rights and Permissions

Zaydman MA, Glaser L, Herman DS, Kressloff M, Azimi V, Lockowitz CR, Dumm RE. Leveraging patient data to detect systematic shifts in daptomycin susceptibility testing associated with reduced prescribing. J Clin Microbiol. 2026 Mar 11;64(3):e0151025. doi: 10.1128/jcm.01510-25.© 2026 Zaydman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

Recommended Citation

Zaydman, Mark A; Glaser, Laurel; Herman, Daniel S; Kressloff, Mason; Azimi, Vahid; Lockowitz, Christine R; and Dumm, Rebekah E, "Leveraging patient data to detect systematic shifts in daptomycin susceptibility testing associated with reduced prescribing." Journal of Clinical Microbiology. 64, 3. e0151025 (2026).
https://digitalcommons.wustl.edu/oa_4/6744

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.